重大事件
外國發行人報告
6-K
2026-07-15
Zentek 聘請 Atrium 提供研究覆蓋，聚焦 Albany 石墨項目與 ZenGUARD 技術
AI 繁中摘要
Zentek Ltd.（TSXV: ZEN | NASDAQ: ZTEK）於2026年7月15日提交6-K表格，披露已聘請Atrium Research Corporation提供公司贊助的研究覆蓋服務。該協議為期18個月，自2026年7月15日起生效，Atrium將根據公開資訊、行業數據及管理層訪談發布研究報告，並舉辦兩場錄製訪談。Zentek每季支付13,200美元（現金）作為服務費用；協議期滿後按季自動續約，直至雙方另行協商或終止。是次合作尚待TSXV批准。
管理層評論要點：
- 行政總裁Mohammed（Moe）Jiwan表示，Atrium的研究覆蓋將為投資者提供更深入分析，包括正在進行初步經濟評估（PEA）的Albany石墨項目（目標今夏完成），以及已產生商業收入的空氣過濾技術平台ZenGUARD™。
- Albany石墨已在實驗室規模提純至5N（99.9992%），符合核級規格及國防市場要求。
- PEA完成後，加上其他項目推進，公司相信專業研究覆蓋有助投資者評估價值。
潛在影響：
- 增加研究覆蓋有助提升Zentek在全球投資界的知名度，尤其針對Albany石墨（北美關鍵礦物供應來源）及ZenGUARD™技術平台。
- 季度費用屬常規贊助研究安排，不影響公司核心營運；Atrium與公司無股權關連，保持獨立性。
是次6-K報告僅披露研究合作，未涉及財務業績變動。投資者應關注PEA進度及商業化里程碑。
展開英文正文
EX-99.1
2
exhibit99-1.htm
EXHIBIT 99.1
Zentek Ltd.: Exhibit 99.1 - Filed by newsfilecorp.com
Zentek Engages Atrium Research Corporation For Company-Sponsored Research Coverage
Company-sponsored research coverage to broaden Zentek's visibility
with the global investment community
Guelph, ON - July 15, 2026 - Zentek Ltd. ("Zentek" or the "Company") (TSXV: ZEN) (NASDAQ: ZTEK) is pleased to announce that it has engaged Atrium Research Corporation ("Atrium"), a company-sponsored research firm, to provide research coverage of the Company.
Atrium will publish research reports on Zentek based on publicly available information, industry data, and discussions with management. Atrium will also host two recorded interviews with Zentek's management team to discuss the Company's business and strategy. In exchange for its research services, Atrium will receive cash compensation of $13,200 per quarter. The services will be provided for a term of 18 months beginning July 15, 2026. At the end of the term, the agreement will remain in place and extend on a quarter-to-quarter basis at $13,200 per quarter, unless otherwise agreed by the parties or terminated by either party. This engagement is subject to TSXV approval.
Atrium and the Company are arm's-length parties, and neither Atrium nor its insiders holds any shares or options to purchase shares in the issued and outstanding capital of the Company.
Management Commentary
"Atrium's research coverage will provide investors with in-depth analysis of Zentek's business, including the Albany Graphite Project, which is currently advancing through a Preliminary Economic Assessment targeted for completion this summer, and ZenGUARD™, our air filtration technology platform, which is already generating commercial revenue. Albany graphite has been purified at bench scale to 5N, consistent with nuclear-grade specifications and defence markets that require that level of purity. As the PEA is completed and we advance our other initiatives, we believe access to well-researched coverage will help investors evaluate the Company," said Mohammed (Moe) Jiwan, Chief Executive Officer of Zentek.
About Zentek
Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. Core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the principal critical minerals asset, advancing toward a PEA targeted for completion in summer 2026.
About Albany Graphite
The Albany Graphite Project is an igneous-hosted graphite deposit located in Northern Ontario, held through the Company's wholly-owned subsidiary Albany Graphite Corp. Independent bench-scale testing conducted in collaboration with American Energy Technologies Company, as previously disclosed by the Company on September 22, 2025, confirmed ultra-high purity of 99.9992% with an equivalent boron concentration of 2.60 ppm, meeting published benchmarks for potential nuclear-grade applications. The Project is being advanced as a potential domestic North American source of critical-grade graphite for nuclear, battery, and defence supply chains. Graphite is designated a critical mineral by both the Government of Canada and the United States Department of Energy.
About Atrium Research
Atrium Research provides institutional-quality, company-sponsored research on public equities in North America. Its investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Its research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, and in-depth valuation analysis. Atrium Research is wholly owned and operated by its co-founders, Ben Pirie and Nicholas Cortellucci.
For more information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: [email protected]
W: www.zentek.com
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.